Precipio DIO Ratio 2011-2026 | PRPO

Annual DIO Ratio Precipio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
22.7	18.4	21.7	33.6	25.8	25.8	23.1	27.2	41.1	4.97	9.41	63.2	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
63.2	4.97	26.4

Quarterly DIO Ratio Precipio

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
22.4	26.6	25.3	-	19.3	19.8	16.6	-	20.3	22.9	27.7	-	33.5	33.5	28.4	-	32.8	29.4	27.7	-	25.6	28.1	22.3	-	22.2	21.8	25.8	-	27.2	28	23.7	-	42.3	51.7	65.4	-	39.5	23.5	6.69	-	10.2	9.81	4.91	-	128	62.7	84.5	-	86	83.3	100	-	114	103	99.6	-	92.5	113	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
128	4.91	43.9

DIO Ratio of other stocks in the Diagnostics research industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	25.4	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	97.1	$ 114.25	-1.07 %	$ 34.7 B	USA
Biomerica BMRA	147	$ 2.17	-	$ 4.98 M	USA
BioNano Genomics BNGO	251	$ 1.2	-0.03 %	$ 6.53 M	USA
Burning Rock Biotech Limited BNR	243	$ 16.5	1.85 %	$ 178 M	China
Aspira Women's Health AWH	32.2	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	21.9	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	48.3	$ 18.32	0.05 %	$ 976 M	USA
Co-Diagnostics CODX	1.69 K	$ 4.4	101.83 %	$ 5.85 M	USA
Charles River Laboratories International CRL	35.3	$ 168.44	-3.13 %	$ 8.35 B	USA
Castle Biosciences CSTL	48.7	$ 24.85	0.04 %	$ 690 M	USA
Oxford Immunotec Global PLC OXFD	210	-	-	$ 562 M	Britain
Quest Diagnostics Incorporated DGX	9.34	$ 197.89	0.37 %	$ 22 B	USA
Danaher Corporation DHR	87.6	$ 190.62	-0.26 %	$ 136 B	USA
DexCom DXCM	115	$ 62.7	0.76 %	$ 24.5 B	USA
Fulgent Genetics FLGT	7.17	$ 16.8	-0.15 %	$ 508 M	USA
Accelerate Diagnostics AXDX	198	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	82.1	$ 92.35	-1.58 %	$ 11.6 B	USA
Global Cord Blood Corporation CO	89.7	-	-	$ 399 M	China
ICON Public Limited Company ICLR	0.213	$ 110.38	-3.34 %	$ 9.1 B	Irlanda
Interpace Biosciences IDXG	29.1	$ 1.96	5.82 %	$ 8.67 M	USA
Fluidigm Corporation FLDM	131	-	1.08 %	$ 308 M	USA
Illumina ILMN	137	$ 127.63	0.2 %	$ 20.3 B	USA
Genetic Technologies Limited GENE	42.1	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	62.8	-	0.12 %	$ 80.1 M	China
Exact Sciences Corporation EXAS	60.9	-	-	$ 19.8 B	USA
Laboratory Corporation of America Holdings LH	18.9	$ 274.94	0.41 %	$ 22.9 B	USA
DermTech DMTK	33.5	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	40.4	$ 76.0	-0.14 %	$ 5.13 B	USA
Enzo Biochem ENZ	156	-	-8.98 %	$ 14.8 K	USA
Mettler-Toledo International MTD	79	$ 1 258.2	-0.3 %	$ 25.9 B	Schweiz
Myriad Genetics MYGN	42.8	$ 4.84	1.79 %	$ 448 M	USA
ENDRA Life Sciences NDRA	405	$ 4.69	-	$ 3.69 M	USA
NeoGenomics NEO	24.4	$ 8.06	0.75 %	$ 1.03 B	USA
Neogen Corporation NEOG	147	$ 9.42	0.11 %	$ 2.04 B	USA
Natera NTRA	25.8	$ 207.01	-0.46 %	$ 20.4 B	USA
Pacific Biosciences of California PACB	173	$ 1.36	1.49 %	$ 408 M	USA
Koninklijke Philips N.V. PHG	89	$ 27.09	-0.07 %	$ 20 B	Niderland
Personalis PSNL	12.1	$ 6.63	0.76 %	$ 393 M	USA